Findings show safety of BNT162b2 or CoronaVac vaccines in patients with cardiovascular disease
ACIP endorsed the shots after hearing the latest evidence on the vaccine's effectiveness
Infants should be placed in supine position, on firm, flat, noninclined surface for every sleep
No evidence of increase seen for short- to medium-term cardiovascular risk, but data lacking regarding long-term safety
Agency noted that lab accidents have triggered some previous outbreaks, so theory could not be discounted
Review shows 2 to 3 g/day may be optimal intake associated with both systolic and diastolic blood pressure reductions
Relative change from 2016 to 2019 varied from −52.0 percent in Mississippi to −6.9 percent in New Hampshire
Moderate improvement in pain severity and response for products with high THC-to-CBD ratios, but side effects are seen
Updates include effects in T2D patients of finerenone on CV outcomes in those with CKD; of SGLT2 inhibitors on heart failure, renal outcomes
